Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator
Clinical trial NCT01802879 · COMPLETED
Trial details
- NCT number
- NCT01802879
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-24
- Primary completion
- 2018-11-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.